Current perspectives in mesenchymal stem cell therapies for osteoarthritis

Stem Cells International

Volumn 2014, Issue , 2014, Pages

  Kristjánsson, Baldur ^a   Honsawek, Sittisak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROCYTE IMPLANTATION; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; GOOD MANUFACTURING PRACTICE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; MENISCECTOMY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOARTHRITIS; OSTEOCHONDRITIS DISSECANS; OSTEOCYTE; POSTOPERATIVE CARE; REVIEW; RHEUMATOID ARTHRITIS; SURGICAL APPROACH; TISSUE REPAIR;

EID: 84919781995     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2014/194318     Document Type: Review

References (85)

1. D. M. Findlay, "If good things come from above, do bad things come frombelow"Arthritis Research and Therapy, vol. 12,no. 3, article 119, 2010
2. M. B. Goldring and S. R. Goldring, "Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis," Annals of theNew York Academy of Sciences, vol. 1192,pp. 230-237, 2010
3. B. J. E. de Lange-Brokaar, A. Ioan-Facsinay, G. J. V. M. vanOsch et al., "Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review," Osteoarthritis and Cartilage, vol. 20, no. 12, pp. 1484-1499, 2012
4. S. A. Haq, F. Davatchi, S. Dahaghin et al., "Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study," International Journal of Rheumatic Diseases, vol. 13, no. 3, pp. 203-214, 2010
5. S. Dahaghin, S. A. Tehrani-Banihashemi, S. T. Faezi, A. R. Jamshidi, and F. Davatchi, "Squatting, sitting on the floor, or cycling: are life-long daily activities risk factors for clinical knee osteoarthritis? Stage III results of a community-based study," Arthritis Care and Research, vol. 61, no. 10, pp. 1337-1342, 2009
6. J. A. Buckwalter and J. A. Martin, "Osteoarthritis," Advanced Drug Delivery Reviews, vol. 58, no. 2, pp. 150-167, 2006
7. M. Gore, K.-S. Tai, A. Sadosky, D. Leslie, and B. R. Stacey, "Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis," Journal of Medical Economics, vol. 14, no. 4, pp. 497-507, 2011
8. G. A. Hawker, S. Mian, K. Bednis, and I. Stanaitis, "Osteoarthritis year 2010 in review: non-pharmacologic therapy," Osteoarthritis and Cartilage, vol. 19, no. 4, pp. 366-374, 2011
9. M. F. Pisters, C. Veenhof, F. G. Schellevis,D. H. DeBakker, and J. Dekker, "Long-termeffectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomized controlled trial comparing two different physical therapy interventions," Osteoarthritis and Cartilage, vol. 18, no. 8, pp. 1019-1026, 2010
10. J. A. Buckwalter, C. Saltzman, and T. Brown, "The impact of osteoarthritis: implications for research," Clinical Orthopaedics and Related Research, no. 427, pp. S6-S15, 2004
11. H. S. Vasiliadis and J. Wasiak, "Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee," Cochrane Database of Systematic Reviews, no. 10, Article ID CD003323, 2010
12. M. Brittberg, A. Lindahl, A. Nilsson, C. Ohlsson, O. Isaksson, and L. Peterson, "Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation," The New England Journal of Medicine, vol. 331, no. 14, pp. 889-895, 1994
13. A. J. Friedenstein, I. I. Piatetzky-Shapiro, and K. V. Petrakova, "Osteogenesis in transplants of bone marrow cells," Journal of Embryology and Experimental Morphology, vol. 16, no. 3, pp. 381-390, 1966
14. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999
15. B. E. Petersen,W. C. Bowen, K. D. Patrene et al., "Bone marrow as a potential source of hepatic oval cells," Science, vol. 284, no. 5417, pp. 1168-1170, 1999
16. G. C. Kopen,D. J. Prockop, and D. G. Phinney, "Marrowstromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10711-10716, 1999
17. C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk, "Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow," Blood, vol. 98, no. 8, pp. 2396-2402, 2001
18. J. M. KarpandG. S. L. Teo, "Mesenchymal stemcell homing: the devil is in the details," Cell Stem Cell, vol. 4, no. 3, pp. 206-216, 2009
19. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease," Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008
20. J. Doorn, G. Moll, K. Le Blanc, C. van Blitterswijk, and J. de Boer, "Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements," Tissue Engineering Part B: Reviews, vol. 18, no. 2, pp. 101-115, 2012
21. L. da Silva Meirelles, A. M. Fontes, D. T. Covas, and A. I. Caplan, "Mechanisms involved in the therapeutic properties of mesenchymal stem cells," Cytokine and Growth Factor Reviews, vol. 20, no. 5-6, pp. 419-427, 2009
22. A. J. B. O. G. Salgado, R. L. G. Reis, N. J. C. Sousa, and J. M. Gimble, "Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine," Current Stem Cell Research and Therapy, vol. 5, no. 2, pp. 103-110, 2010
23. M. Abumaree,M. Al Jumah, R. A. Pace, and B. Kalionis, "Immunosuppressive properties of mesenchymal stem cells," Stem Cell Reviews and Reports, vol. 8, no. 2, pp. 375-392, 2012
24. B. A. Bunnell, B. T. Estes, F. Guilak, and J. M. Gimble, "Differentiation of adipose stem cells," Methods in Molecular Biology, vol. 456, pp. 155-171, 2008
25. M. Crisan, S. Yap, L. Casteilla et al., "A perivascular origin for mesenchymal stem cells in multiple human organs," Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008
26. D. L. Troyer and M. L. Weiss, "Wharton's Jelly-derived cells are a primitive stromal cell population," Stem Cells, vol. 26, no. 3, pp. 591-599, 2008
27. P. J. Simmons and B. Torok-Storb, "Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1," Blood, vol. 78, no. 1, pp. 55-62, 1991
28. L. da Silva Meirelles and N. B. Nardi, "Methodology, biology and clinical applications of mesenchymal stem cells," Frontiers in Bioscience, vol. 14, no. 11, pp. 4281-4298, 2009
29. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement," Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006
30. A. Mehrkens, N. Di Maggio, S. Gueven et al., "Non-adherent mesenchymal progenitors from adipose tissue stromal vascular fraction," Tissue Engineering-Part A, vol. 20, no. 5-6, pp. 1081-1088, 2014
31. Z. L. Zhang, J. Tong, R. N. Lu, A. M. Scutt, D. Goltzman, and D. S. Miao, "Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration," Bone Marrow Transplantation, vol. 43, no. 1, pp. 69-81, 2009
32. A. Farini, C. Sitzia, S. Erratico, M. Meregalli, and Y. Torrente, "Clinical applications of mesenchymal stem cells in chronic diseases," Stem Cells International, vol. 2014, Article ID 306573, 11 pages, 2014
33. H. J. Paek, C. Kim, and S. K. Williams, "Adipose stemcell-based regenerative medicine for reversal of diabetic hyperglycemia," World Journal of Diabetes, vol. 5, no. 3, pp. 235-243, 2014
34. T. K. Ng, V. R. Fortino, D. Pelaez, and H. S. Cheung, "Progress of mesenchymal stem cell therapy for neural and retinal diseases," World Journal of Stem Cells, vol. 6, no. 2, pp. 111-119, 2014
35. M. E. Bernardo, N. Zaffaroni, F. Novara et al., "Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms," Cancer Research, vol. 67, no. 19, pp. 9142-9149, 2007
36. L. He, Y. Zheng, Y. Wan, and J. Song, "A shorter telomere is the key factor in preventing cultured humanmesenchymal stem cells from senescence escape," Histochemistry and Cell Biology, vol. 142, no. 3, pp. 257-267, 2014
37. K. Suzuki,R. Sun, M. Origuch et al., "Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization," MolecularMedicine, vol. 17,no. 7-8, pp. 579-587, 2011
38. C. De Bari, F. Dell'Accio, P. Tylzanowski, and F. P. Luyten, "Multipotent mesenchymal stem cells from adult human synovial membrane," Arthritis & Rheumatism, vol. 44, no. 8, pp. 1928-1942, 2001
39. Y. Segawa, T. Muneta, H. Makino et al., "Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles," Journal of Orthopaedic Research, vol. 27,no. 4, pp. 435-441, 2009
40. A. F. Steinert,M. Kunz, P. Prager et al., "Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells," Tissue Engineering-Part A, vol. 17, no. 9-10, pp. 1375-1388, 2011
41. W. S. Khan, A. B. Adesida, S. R. Tew, U. G. Longo, and T. E. Hardingham, "Fat pad-derived mesenchymal stem cells as a potential source for cell-based adipose tissue repair strategies," Cell Proliferation, vol. 45, no. 2, pp. 111-120, 2012
42. R. Williams, I. M. Khan, K. Richardson et al., "Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage," PLoS ONE, vol. 5, no. 10, Article ID e13246, 2010
43. A. Karystinou, F. Dell'Accio, T. B. A. Kurth et al., "Distinct mesenchymal progenitor cell subsets in the adult human synovium," Rheumatology, vol. 48, no. 9, pp. 1057-1064, 2009
44. M. Horie, M. D. Driscoll, H. W. Sampson et al., "Implantation of allogenic synovial stem cells promotesmeniscal regeneration in a rabbit meniscal defect model," Journal of Bone and Joint Surgery A, vol. 94, no. 8, pp. 701-712, 2012
45. F. Barry and M. Murphy, "Mesenchymal stem cells in joint disease and repair," Nature Reviews Rheumatology, vol. 9, no. 10, pp. 584-594, 2013
46. C. R. Flannery, C. E. Hughes, B. L. Schumacher et al., "Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is amultifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism," Biochemical and Biophysical Research Communications, vol. 254, no. 3, pp. 535-541, 1999
47. J. M. Rosen and C. T. Jordan, "The increasing complexity of the cancer stem cell paradigm," Science, vol. 324, no. 5935, pp. 1670-1673, 2009
48. J.-H. Chen, C. Y. Y. Yip, E. D. Sone, and C. A. Simmons, "Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential," The American Journal of Pathology, vol. 174, no. 3, pp. 1109-1119, 2009
49. O. Bock, J. Höftmann, K. Theophile et al., "Bonemorphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines," The American Journal of Pathology, vol. 172, no. 4, pp. 951-960, 2008
50. D. H. Lee, C. H. Sonn, S. B. Han, Y. Oh, K. M. Lee, and S. H. Lee, "Synovial fluid CD34? CD44+ CD90+ mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis," Osteoarthritis and Cartilage, vol. 20, no. 2, pp. 106-109, 2012
51. J. M. Murphy, K. Dixon, S. Beck, D. Fabian, A. Feldman, and F. Barry, "Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis," Arthritis & Rheumatism, vol. 46, no. 3, pp. 704-713, 2002
52. K.-H. Chua,W. K. Z. W. Safwani, A. A. Hamid, S. K. Shuhup, N. H. M. Haflah, and N. H. M. Yahaya, "Retropatellar fat padderived stem cells from older osteoarthritic patients have lesser differentiation capacity and expression of stemness genes," Cytotherapy, vol. 16, no. 5, pp. 599-611, 2014
53. C. J. Centeno, J. R. Schultz, M. Cheever, B. Robinson, M. Freeman, and W. Marasco, "Safety and complications reporting on the re-implantation of culture-expandedmesenchymal stem cells using autologous platelet lysate technique," Current Stem Cell Research and Therapy, vol. 5, no. 1, pp. 81-93, 2010
54. A. Scharstuhl, B. Schewe, K. Benz, C. Gaissmaier, H.-J. Büuhring, and R. Stoop, "Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology," StemCells, vol. 25, no. 12, pp. 3244-3251, 2007
55. A. Gobbi, D. Lad, and G. Karnatzikos, "The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee," Knee Surgery, Sports Traumatology, Arthroscopy, 2014
56. S. Wakitani, T. Goto, S. J. Pineda et al., "Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage," Journal of Bone and Joint Surgery, vol. 76, no. 4, pp. 579-592, 1994
57. L. Aust, B. Devlin, S. J. Foster et al., "Yield of human adiposederived adult stem cells from liposuction aspirates," Cytotherapy, vol. 6, no. 1, pp. 7-14, 2004
58. S. R. Burger, "Current regulatory issues in cell and tissue therapy," Cytotherapy, vol. 5, no. 4, pp. 289-298, 2003
59. N. Fekete, M. T. Rojewski, D. Fürst et al., "GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC," PLoS ONE, vol. 7, no. 8,Article ID e43255, 2012
60. S. Wakitani, T. Mitsuoka, N. Nakamura, Y. Toritsuka, Y. Nakamura, and S. Horibe, "Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports," Cell Transplantation, vol. 13, no. 5, pp. 595-600, 2004
61. S. Wakitani, K. Imoto, T. Yamamoto, M. Saito, N. Murata, and M. Yoneda, "Human autologous culture expanded bonemarrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees," Osteoarthritis and Cartilage, vol. 10, no. 3, pp. 199-206, 2002
62. R. Kuroda, K. Ishida, T. Matsumoto et al., "Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells," Osteoarthritis and Cartilage, vol. 15, no. 2, pp. 226-231, 2007
63. S. Wakitani, M. Nawata, K. Tensho, T. Okabe, H. Machida, and H. Ohgushi, "Repair of articular cartilage defects in the patellofemoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees," Journal of Tissue Engineering and RegenerativeMedicine, vol. 1, no. 1, pp. 74-79, 2007
64. S. Wakitani, T. Okabe, S. Horibe et al., "Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months," Journal of Tissue Engineering and Regenerative Medicine, vol. 5, no. 2, pp. 146-150, 2011
65. M. Kaszkin-Bettag, "Is autologous chondrocyte implantation (ACI) an adequate treatment option for repair of cartilage defects in paediatric patients" Drug Discovery Today, vol. 18, no. 15-16, pp. 740-747, 2013
66. H. Nejadnik, J. H. Hui, E. P. F. Choong, and B.-C. Tai, "Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study," The American Journal of Sports Medicine, vol. 38, no. 6, pp. 1110-1116, 2010
67. R. Buda, F. Vannini,M. Cavallo, B. Grigolo, A. Cenacchi, and S. Giannini, "Osteochondral lesions of the knee: a new one-step repair technique with bone-marrow-derived cells," Journal of Bone and Joint Surgery-Series A, vol. 92, no. 2, pp. 2-11, 2010
68. A. Gobbi, G. Karnatzikos, C. Scotti, V. Mahajan, L. Mazzucco, and B. Grigolo, "One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up," Cartilage, vol. 2, no. 3, pp. 286-299, 2011
69. A. Gobbi, G. Karnatzikos, and S. R. Sankineani, "One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee," The American Journal of Sports Medicine, vol. 42, no. 3, pp. 648-657, 2014
70. C. J. Centeno, D. Busse, J. Kisiday, C. Keohan, M. Freeman, and D. Karli, "Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologousmesenchymal stem cells," Pain Physician, vol. 11, no. 3, pp. 343-353, 2008
71. C. J. Centeno, D. Busse, J. Kisiday, C. Keohan,M. Freeman, and D. Karli, "Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells," Medical Hypotheses, vol. 71, no. 6, pp. 900-908, 2008
72. F. Davatchi, B. S. Abdollahi,M. Mohyeddin, F. Shahram, and B. Nikbin, "Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients," International Journal of Rheumatic Diseases, vol. 14, no. 2, pp. 211-215, 2011
73. M. Emadedin, N. Aghdami, L. Taghiyar et al., "Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis," Archives of Iranian Medicine, vol. 15, no. 7, pp. 422-428, 2012
74. L. Orozco, A. Munar, R. Soler et al., "Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study," Transplantation, vol. 95, no. 12, pp. 1535-1541, 2013
75. D. Goyal, S. Keyhani, E. H. Lee, and J. H. P. Hui, "Evidencebased status of microfracture technique: a systematic review of level I and II studies," Arthroscopy, vol. 29, no. 9, pp. 1579-1588, 2013
76. K.-Y. Saw, A. Anz, C. Siew-Yoke Jee et al., "Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial," Arthroscopy, vol. 29, no. 4, pp. 684-694, 2013
77. K. Y. Saw, A. Anz, S. Merican et al., "Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology," Arthroscopy, vol. 27, no. 4, pp. 493-506, 2011
78. K. L. Wong, K. B. L. Lee, B. C. Tai, P. Law, E. H. Lee, and J. H. P. Hui, "Injectable culturedbonemarrow-derivedmesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up," Arthroscopy-Journal of Arthroscopic and Related Surgery, vol. 29, no. 12, pp. 2020-2028, 2013
79. Y.-G. Koh and Y.-J. Choi, "Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis," Knee, vol. 19, no. 6, pp. 902-907, 2012
80. Y.-G. Koh, S.-B. Jo, O.-R. Kwon et al., "Mesenchymal stem cell injections improve symptoms of knee osteoarthritis," Arthroscopy, vol. 29, no. 4, pp. 748-755, 2013
81. Y.-G. Koh, Y.-J. Choi, S.-K. Kwon, Y.-S. Kim, and J.-E. Yeo, "Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis," Knee Surgery, Sports Traumatology, Arthroscopy, 2013
82. C. H. Jo, Y. G. Lee, W. H. Shin et al., "Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial," Stem Cells, vol. 32, no. 5, pp. 1254-1266, 2014
83. C. T. Vangsness Jr., J. Farr, J. Boyd, D. T. Dellaero, C. R. Mills, and M. LeRoux-Williams, "Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy," The Journal of Bone and Joint Surgery A, vol. 96, no. 2, pp. 90-98, 2014
84. H. S. Varma, B. Dadarya, and A. Vidyarthi, "Thenew avenues in themanagement of osteo-arthritis of knee-stem cells," Journal of the Indian Medical Association, vol. 108, no. 9, pp. 583-585, 2010
85. R. A. Hauser and A. Orlofsky, "Regenerative injection therapy with whole bonemarrow aspirate for degenerative joint disease: a case series," Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, vol. 6, pp. 65-72, 2013.